The RNF111 antibody is an affinity-purified polyclonal antibody generated in rabbits, targeting the human RNF111 protein. It is widely used in techniques like immunohistochemistry (IHC) and immunofluorescence (IF) to visualize RNF111's expression and localization in tissues and cells . RNF111 itself is an E3 ubiquitin-protein ligase involved in critical pathways, including transforming growth factor-beta (TGF-β) signaling and antiviral responses .
RNF111 facilitates nucleotide excision repair (NER) by promoting ubiquitination of SUMOylated substrates, such as XPC, a DNA damage recognition factor. Depletion of RNF111 impairs UV-induced XPC ubiquitylation, highlighting its role in DNA damage response .
RNF111 enhances the cGAS-STING (cyclic GMP-AMP synthase–stimulator of interferon genes) pathway by mediating neddylation of cGAS. This modification strengthens cGAS dimerization and DNA-binding capacity, critical for antiviral defense. Studies in Rnf111-deficient mice showed reduced interferon production and increased susceptibility to herpes simplex virus 1 (HSV-1) .
RNF111 interacts with SMAD proteins (e.g., SMAD3 and SMAD7) to regulate TGF-β signaling, influencing processes like embryonic development and cancer progression .
Specificity: Recognizes unmodified RNF111 protein in human tissues .
Immunohistochemistry: Staining patterns consistent with nuclear localization in multiple tissue types (per Human Protein Atlas) .
Protein Array Testing: Validated against 364 human recombinant protein fragments to ensure minimal cross-reactivity .